Markets:

Overview

News

Currencies

International

Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

15.63 -0.19 (-1.20%)

Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

35 36 Next >

Hims & Hers Health Stock Plunges Over 13% In Tuesday Pre-Market: What's Going On? ↗

August 05, 2025

Hims & Hers Health Inc. (NYSE: HIMS) plunged 13.1% in Tuesday pre-market after the digital health company reported second-quarter revenue on Monday that missed Wall Street expectations.

Via Benzinga

Palantir, Hims & Hers, American Eagle, Joby Aviation And AMD: Why These 5 Stocks Are On Investors' Radars Today ↗

August 04, 2025

Major U.S. indices ended Monday in the green with the Dow Jones Industrial Average rising 1.3% higher at 44,173.64.

Via Benzinga

Topics Stocks

Hims & Hers Tumbles After-Hours On Q2 Miss, GLP-1 Slowdown — But Retail Traders Eye Bargain Entry ↗

August 04, 2025

Via Stocktwits

Hims & Hers (HIMS) Q2 Revenue Jumps 73% ↗

August 04, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 04, 2025

Via Benzinga

Earnings Scheduled For August 4, 2025 ↗

August 04, 2025

Via Benzinga

What Does the Market Think About Hims & Hers Health? ↗

August 01, 2025

Via Benzinga

Hims & Hers Health Earnings Preview ↗

August 01, 2025

Via Benzinga

Which stocks are moving after the closing bell on Monday? ↗

August 04, 2025

After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

Hims & Hers Health (NYSE:HIMS) Misses Q2 Revenue Estimates, Stock Drops 12%

August 04, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q2 CY2025, but sales rose 72.6% year on year to $544.8 million. On the other hand, the company...

Via StockStory

Hims & Hers Health Stock Tumbles On Q2 Earnings As Revenue Comes Up Short, Company Sees 'Exciting Period Of Growth' Ahead ↗

August 04, 2025

Hims & Hers Health reports second-quarter revenue of $544.83 million, missing analyst estimates of $549.83 million.

Via Benzinga

IBD 50's Hims & Hers Plummets 9% On Second-Quarter Sales Miss ↗

August 04, 2025

The company reiterated its sales outlook for the year, despite coming in with lighter-than-expected second-quarter sales.

Via Investor's Business Daily

Topics ETFs Earnings

Check Out What Whales Are Doing With HIMS ↗

August 01, 2025

Via Benzinga

This Biotech Stock Could Soar on Upcoming Clinical Data ↗

August 04, 2025

This weight loss drugmaker may be significantly undervalued right now.

Via The Motley Fool

2 Healthcare Stocks That Have Doubled Over the Last Year but Still Have Room to Run ↗

August 03, 2025

These top telehealth stocks look like smart growth plays right now.

Via The Motley Fool

What To Expect From Hims & Hers Health’s (HIMS) Q2 Earnings

August 02, 2025

Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence Economy World Trade

Will Hims & Hers Fall Along With Novo Nordisk? ↗

August 01, 2025

Novo Nordisk shares are trading as low as 35% of their 52-week highs, making Hims & Hers investors nervous whether a selloff is coming.

Via MarketBeat

EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank? ↗

August 01, 2025

Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers.

Via Benzinga

August 01, 2025

Wall Street has issued downbeat forecasts for the stocks in this article. These predictions are rare - financial institutions typically hesitate to say bad things about a company because it can...

Via StockStory

Hims & Hers Stock Up, Nearing All-Time High As Weight-Loss Giants Stumble ↗

July 31, 2025

Shares of telehealth company Hims & Hers Health are up Thursday afternoon. The rally comes amid significant headwinds for major pharmaceutical companies in the lucrative weight-loss drug market.

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

July 30, 2025

Via Benzinga

Novo Nordisk Charts Signal Weakness Amid Wegovy Warning, Expert Says 'Could've Played Out VERY Differently If They Had Embraced $HIMS' ↗

July 30, 2025

Novo Nordisk's technical chart is displaying a largely bearish trend amid a profit warning tied to its blockbuster obesity drug Wegovy.

Via Benzinga

What's Going On With Eli Lilly Stock On Tuesday? ↗

July 29, 2025

Eli Lilly stock slips after Novo Nordisk trims 2025 forecast; Jaypirca meets endpoint in CLL trial against J&J's Imbruvica, with more data expected.

Via Benzinga

Novo Nordisk Implodes After Wegovy Warning—Is The Weight-Loss Bubble Bursting? ↗

July 29, 2025

Novo Nordisk stock collapsed 26% in its worst trading day ever after slashing guidance on Wegovy sales and naming a new CEO.

Via Benzinga

HIMS & HERS HEALTH INC (NYSE:HIMS) Fits Minervini’s Trend Template and High-Growth Momentum Strategy ↗

July 28, 2025

HIMS & HERS HEALTH INC (NYSE:HIMS) excels in both technical momentum and high-growth fundamentals, fitting Mark Minervini’s trend strategy with strong earnings, revenue growth, and rising stock...

Via Chartmill

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet ↗

July 26, 2025

The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the week and a look at the reasons why and what's next.

Via Benzinga

Hims & Hers Stock Could Rocket To Meme Stock Fame — If Short Sellers Feel The Squeeze ↗

July 25, 2025

Hims & Hers stock has many of the key ingredients for a retail-driven rally.

Via Benzinga

2 Digital Healthcare Stocks Poised for a Breakout ↗

July 24, 2025

Digital disruptors are the future of the healthcare industry. Here are two stocks in the space to consider.

Via The Motley Fool

Topics Artificial Intelligence

What's Going On With Hims & Hers Stock Wednesday? ↗

July 23, 2025

HIMS stock up 16% on Wednesday, continuing month-long gains. Novo Nordisk ends partnership, cites misleading marketing and safety concerns.

Via Benzinga

History of Hims & Hers Health: Revolutionizing Personal Wellness Through Telehealth (NYSE:HIMS)

July 21, 2025

Hims & Hers Health has emerged as a transformative force in the personal wellness industry, redefining the intersection of healthcare, technology, and consumer convenience. With the telehealth sector...

Via MarketMinute

Topics Initial Public Offering

< Previous 1 2

...

5 6 7 8 9 10 11 12 13

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

Headline News about Hims & Hers Health, Inc. Class A Common Stock

Starting at $3.75/week.

Subscribe Today